Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Originalspråk	engelska
Sidor (från-till)	675
Tidskrift	Nature Reviews Rheumatology
Volym	19
Nummer	10
Tidigt onlinedatum	2023 aug. 21
DOI	https://doi.org/10.1038/s41584-023-01013-4
Status	Published - 2023

Ämnesklassifikation (UKÄ)

@article{6378d1a197324f71b816f36e0f32111b,

title = "Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?",

author = "Kristofer Andr{\'e}asson and Viggo Hamberg and Jenny Wig{\'e}n and Gunilla Westergren-Thorsson",

year = "2023",

doi = "10.1038/s41584-023-01013-4",

language = "English",

volume = "19",

pages = "675",

journal = "Nature Reviews Rheumatology",

issn = "1759-4804",